The Global Intra Uterine contraceptive Devices market is estimated to be USD 1,370 million in 2016 and is expected to reach USD 2,267 million by 2021, growing at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2016 to 2021.
IUDs are small contraceptive devices, often T-shaped, containing either copper or levonorgestrel, which are inserted into the uterus. They are a form of long-acting contraception and are the most effective type of reversible birth control.
Global IUD Market- Market Dynamics
The report details several factors driving and restraining the global market for IUDs. The opportunities and challenges for the market are also discussed. Some of these are listed below.
Increase in the prevalence of Sexually Transmitted Diseases (STD)
Immediate health benefits other than birth control
Rise in government initiatives to prevent unwanted abortions and pregnancies
Cultural or religious oppositions prevalent in many countries
Limited access to contraception
Opportunities and Challenges
The new products that are in the research pipeline and the belief that IUDs are the safest contraceptives are some of the market opportunities for the key players. However, they also face the challenge of dealing with the threat of Pelvic Inflammatory Infection (PFD) and ectopic pregnancy as a result of the use of IUDs.
The global IUD market is broadly segmented based on the type and product. Based on the type, the market is further segmented into hormonal intrauterine device and copper intrauterine device market. Based on the product, the market is segmented into MIRENA, SKYLA, PARAGARD, ESSURE, LEVOSERT and others.
Based on geographical location, the intrauterine device market can be divided into North America (the USA, Canada, and Mexico), Europe (France, UK, Germany, Spain, Portugal, Scandinavia and Italy), Asia-Pacific (India, China, Japan, South Korea, Australia, and New Zealand), Middle East and Africa (GCC, Egypt) and Latin America (Brazil and Argentina).
Some of the key players in the market are:
ANI Pharmaceuticals, Inc.
Church & Dwight, Co. Inc.
Fuji Latex Co., Ltd
Johnson & Johnson, Ltd
Lupin Pharmaceuticals, Ltd
Okamato Industries, Inc.
Key Deliverables in the Study
Market analysis for the Intra Uterine Devices Market, with global and region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.
Identification and analysis of the macro and micro factors that affect the intrauterine device market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
Manager – Partner Relations & International Marketing
Ph: +1-214-377-1121 (US)/ +44-020-3286-9338 (UK)